Switching from intravenous to subcutaneous VEDOlizumab formulation in ulcerative colitis patients in clinical remission: the SVEDO Study, a multicenter IG-IBD study

被引：0

作者：

Ribaldone, D. G. ^{[1
]}

Parisio, L. ^{[2
]}

Variola, A. ^{[3
]}

Bossa, F. ^{[4
]}

Castiglione, F. ^{[5
]}

Marzo, M. ^{[6
]}

Piazza, N. ^{[7
]}

Aratari, A. ^{[8
]}

Savarino, E. V. ^{[9
]}

Bodini, G. ^{[10
]}

Mastronardi, M. ^{[11
]}

Micheli, F. ^{[2
,12
]}

Mazzuoli, S. ^{[13
]}

Ascolani, M. ^{[14
]}

Vigano, C. ^{[15
,16
]}

Cappello, M. ^{[17
]}

Bezzio, C. ^{[18
]}

Ciccocioppo, R. ^{[19
,20
]}

Scardino, G. ^{[21
]}

Sarli, E. ^{[22
]}

Pugliese, D. ^{[2
]}

Scaldaferri, F. ^{[2
]}

Napolitano, D. ^{[2
]}

Todeschini, A. ^{[3
]}

Geccherle, A. ^{[3
]}

Colaci, N. ^{[23
]}

Guerra, M. ^{[4
]}

Annese, M. ^{[4
]}

Testa, A. ^{[5
]}

Caiazzo, A. ^{[5
]}

Conforti, F. S. ^{[7
]}

Festa, S. ^{[8
]}

Lorenzon, G. ^{[9
]}

Marra, A. ^{[11
]}

Magiotta, A. ^{[12
]}

Baccini, F. ^{[12
]}

Amato, A. ^{[24
]}

Vernero, M. ^{[1
]}

Caprioli, F. ^{[25
]}

Caviglia, G. P. ^{[1
]}

机构：

[1] Univ Turin, Dept Med Sci, Turin, Italy

[2] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, CEAMD IBD Unit, Rome, Italy

[3] IRCCS Osped Sacro Cuore Don Calabria, IBD Unit, Negrar Di Valpolicella, VR, Italy

[4] Fdn IRCCS Casa Sollievo della Sofferenza, Div Gastroenterol & Endoscopy, San Giovanni Rotondo, FG, Italy

[5] Sch Med Federico II Naples, Gastroenterol, Dept Clin Med & Surg, Naples, Italy

[6] Osped Veris delli Ponti, UOC Gastroenterol, Scorrano, LE, Italy

[7] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Gastroenterol & Endoscopy Unit, Milan, Italy

[8] San Filippo Neri Hosp, IBD Unit, Rome, Italy

[9] Univ Padua, Azienda Osped Univ Padova, Gastroenterol Unit, Dept Surgery Oncol & Gastroenterol, Padua, Italy

[10] Univ Genoa, Dept Internal Med, IRCCS Policlin San Martino, Genoa, Italy

[11] IRCCS S De Bellis, Unita Operat Semplice Dipartimentale IBD, Castellaneta Grotte, BA, Italy

[12] Sapienza Univ Rome, St Andrea Hosp, Digest Dis Unit, Rome, Italy

[13] Osped Dimiccoli Barletta, Gastroenterol & Endoscopy Unit, Barletta, Italy

[14] ULSS2 Marca Trevigiana Osped Ca Foncello, UOC Gastroenterol, Treviso, Italy

[15] Univ Milano Bicocca, Fdn IRCCS San Gerardo Tintori, Sch Med, Dept Gastroenterol, Monza, Italy

[16] European Reference Network Hepatol Dis ERN RARE L, Ctr Autoimmune Liver Dis, Monza, Italy

[17] AOUP P Giaccone, UOC Gastroenterol, Palermo, Italy

[18] ASST Rhodense, Rho Hosp, Gastroenterol Unit, IBD Ctr, Milan, Italy

[19] AOUI Policlin GB Rossi, Verona, Italy

[20] Univ Verona, Gastroenterol Unit, Dept Med, Verona, Italy

[21] Valduce Hosp, Dept Gastroenterol, Como, Italy

[22] Italian Grp Study Inflammatory Bowel Dis, IG IBD, Florence, Italy

[23] IRCCS Sacro Cuore Don Calabria, Unita Ric Clin, Negrar Di Valpolicella, VR, Italy

[24] ASST Lecco, Digest Endoscopy & Gastroenterol Dept, Lecce, Italy

[25] Univ Milan, Gastroenterol & Endoscopy Unit, Dept Pathophysiol & Transplantat, Fdn IRCCS Ca Granda,Osped Maggiore Policlin Milan, Milan, Italy

来源：

JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P612

引用

页码：I1176 / I1176

页数：1

共 50 条

[21] Safety and efficacy of vedolizumab in pediatric patients with ulcerative colitis: multicenter study in Japan
Yokoyama, Koji
Yamamoto, Yoko
Nambu, Ryusuke
Hagiwara, Shin-Ichiro
Abukawa, Daiki
Mizuochi, Tatsuki
Kudo, Takahiro
Sado, Tomomitsu
Iwata, Naomi
Ishige, Takashi
Iwama, Itaru
Kumagai, Hideki
Arai, Katsuhiro
Shimizu, Toshiaki
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 (07) : 1107 - 1115
[22] Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: The IG-IBD LIVE study
Pugliese, Daniela
Privitera, Giuseppe
Crispino, Federica
Mezzina, Nicolo
Castiglione, Fabiana
Fiorino, Gionata
Laterza, Lucrezia
Viola, Anna
Bertani, Lorenzo
Caprioli, Flavio
Cappello, Maria
Barberio, Brigida
Ricci, Chiara
Balestrieri, Paola
Daperno, Marco
Pluchino, Dario
Rizzello, Fernando
Scribano, Maria Lia
Sablich, Renato
Pastorelli, Luca
Manguso, Francesco
Variola, Angela
Di Sario, Antonio
Grossi, Laurino
Armuzzi, Alessandro
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (01) : 95 - 109
[23] Clinical Effectiveness of Vedolizumab in Chinese Ulcerative Colitis Patients: Results From the VALUE Study
Chen, Baili
Xie, Li
Liu, Yameng
Chen, Minhu
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S213 - S214
[24] Colorectal cancer and high grade dysplasia complicating ulcerative colitis in Italy - A retrospective co-operative IG-IBD study
Riegler, G
Bossa, F
Caserta, L
Pera, A
Tonelli, F
Sturniolo, GC
Oliva, L
Avesani, EC
Poggioli, G
DIGESTIVE AND LIVER DISEASE, 2003, 35 (09) : 628 - 634
[25] Clinical Effectiveness of Vedolizumab in Chinese Patients for Ulcerative Colitis: Interim Results From the VALUE Study
Chen, Yan
Fan, Yihong
Qian, Xiaoyu
Xie, Li
Chen, Minhu
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S894 - S895
[26] Persistence of subcutaneous infliximab after switching from intravenous in a French national cohort of IBD patients in remission
Mathieu, N.
Riviere, P.
Heluwaert, F.
Hebuterne, X.
Chupin, A.
Bouguen, G.
Vuitton, L.
Allez, M.
Montuclard, C.
Nachury, M.
Nancey, S.
Amelie, B.
Gilletta, C.
Abitbol, V.
Altwegg, R.
De Maissin, A.
Plastaras, L.
Soune, P. Ah
Boureille, A.
Bouhnik, Y.
Seksik, P.
Chanteloup, E.
Marion, S.
Uzzan, M.
Andrau, P.
Rouillon, C.
Arondel, Y.
Biroulet, L. Peyrin
Laharie, D.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 533 - 534
[27] PERSISTENCE OF SUBCUTANEOUS INFLIXIMAB AFTER SWITCHING FROM INTRAVENOUS IN A FRENCH NATIONAL COHORT OF IBD PATIENTS IN REMISSION
Mathieu, Nicolas
Riviere, Pauline
Heluwaert, Frederic
Hebuterne, Xavier
Chupin, Antoine
Guillaume, Bouguen
Vuitton, Lucine
Allez, Matthieu
Montuclard, Celine
Nachury, Maria
Nancey, Stephane
Biron, Amelie
Giletta, Cyrielle
Abitbol, Vered
Altwegg, Romain
De Maissin, Astrid
Plastaras, Laurianne
Soune, Philippe Ah
Bourreille, Arnaud
Bouhnik, Yoram
Seksik, Philippe
Chanteloup, Elise
Simon, Marion
Uzzan, Mathieu
Andrau, Pierre
Rouillon, Clea
Arondel, Yves
Peyrin-Biroulet, Laurent
Laharie, David
GASTROENTEROLOGY, 2023, 164 (06) : S1118 - S1118
[28] Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United Kingdom
Lim, Samuel Hsiang
Gros, Beatriz
Sharma, Esha
Lehmann, Anouk
Lindsay, James O.
Caulfield, Louise
Gaya, Daniel R.
Taylor, Jo
Limdi, Jimmy
Kwok, Jon
Shuttleworth, Elinor
Dhar, Anjan
Burdge, Gemma
Selinger, Christian
Cococcia, Sara
Murray, Charles
Balendran, Karthiha
Raine, Tim
George, Becky
Walker, Gareth
Aldridge, Robin
Irving, Peter
Lees, Charlie W.
Samaan, Mark
INFLAMMATORY BOWEL DISEASES, 2023, 30 (08) : 1284 - 1294
[29] TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB VERSUS VEDOLIZUMAB TREATMENT: A PROSPECTIVE MULTICENTER STUDY
Brescia, I., V
Principi, M. B.
Ditonno, I
Stasi, E.
Mazzuoli, S.
Lacavalla, I
Di Leo, A.
DIGESTIVE AND LIVER DISEASE, 2024, 56 : S242 - S242
[30] Clinical remission prior to initiation of immumusuppression with azathioprine positively impacts responsiveness in Crohn's disease but not in ulcerative colitis - Results from a multicenter study in 1176 patients with IBD
Holtmann, Martin H.
Krummenauer, Frank
Claas, Christina
Kremeyer, Kristina
Lorenz, D. R.
Vogel, Iris
Rainer, Olivia
Luegering, Norbert
Gerken, Guido
Kruis, Wolfgang
Boehm, Stephan
Stein, Juergen
Boecker, Ulrich
Schmidt, Jan
Herfarth, Hans
Buening, Carsten
Duchmann, Rainer
Sturm, Andreas
Reinshagen, Max
Stallmach, Andreas
Hommes, Daan
D'Haens, Geert
Galle, Peter
Neurath, Markus
GASTROENTEROLOGY, 2006, 130 (04) : A655 - A655

← 1 2 3 4 5 →